ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium

L. Karimi (Rotterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), M. Engelkes (Rotterdam, Netherlands), N. Hernandez-Pacheco (Santa Cruz de Tenerife, Spain), N. Farzan (Amsterdam, Netherlands), P. Soares (Brighton, United Kingdom), B. Francis (Liverpool, United Kingdom), M. Pino-Yanes (Santa Cruz de Tenerife, Spain), C. Eng (San Francisco, United States of America), S. Mukhopadhyay (Brighton, United Kingdom), M. Schieck (Regensburg, Germany), M. Kabesch (Regensburg, Germany), E. Burchard (San Francisco, United States of America), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), H. Janssens (Rotterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands)

Source: International Congress 2019 – Genes and environment
Session: Genes and environment
Session type: Poster Discussion
Number: 5388
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Karimi (Rotterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), M. Engelkes (Rotterdam, Netherlands), N. Hernandez-Pacheco (Santa Cruz de Tenerife, Spain), N. Farzan (Amsterdam, Netherlands), P. Soares (Brighton, United Kingdom), B. Francis (Liverpool, United Kingdom), M. Pino-Yanes (Santa Cruz de Tenerife, Spain), C. Eng (San Francisco, United States of America), S. Mukhopadhyay (Brighton, United Kingdom), M. Schieck (Regensburg, Germany), M. Kabesch (Regensburg, Germany), E. Burchard (San Francisco, United States of America), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), H. Janssens (Rotterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands). ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium. 5388

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genome-wide association study of asthma exacerbations in European children treated with inhaled corticosteroids
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017


LSC 2013 abstract - ST13 and ORMDL3 polymorphisms affect the risk of exacerbations in steroid-treated asthmatic children and young adults
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


A genome-wide association study of severe asthma exacerbations in Latino children and adolescents
Source: Eur Respir J, 57 (4) 2002693; 10.1183/13993003.02693-2020
Year: 2021



Determinants of incident asthma-COPD overlap compared to asthma and COPD alone: A prospective study of 55,110 middle-aged adults
Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics
Year: 2017



Twelve-year asthma incidence in asymptomatic bronchial responsiveness in adults and children from the EGEA study
Source: Annual Congress 2007 - Risk factors for prevalence and incidence of asthma
Year: 2007


Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children.
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Rates of asthma exacerbations are not affected by beta2-adrenergic receptor genotype in patients with persistent asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 708s
Year: 2005

A polymorphism in DNASE1L3 is associated with severe asthma exacerbations in two-high risk populations for asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Genome-wide association study of inhaled corticosteroid response in African-admixed children with asthma.
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Efficacy of montelukast in Indian patients having chronic persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003

Risk factors for severe bronchial asthma in young adults with childhood-onset asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Comparing asthma phenotypes in adults and children: a cohort of two years
Source: Annual Congress 2007 - Risk factors for childhood asthma: cohort studies
Year: 2007


Nickel allergy is associated with wheezing and asthma in a cohort of young German adults: results from the SOLAR study
Source: ERJ Open Res, 6 (1) 00178-2019; 10.1183/23120541.00178-2019
Year: 2020



Association between genetic polymorphisms of the β2-AR and response to salbutamol in patients with atopic bronchial asthma of Kyrgyz nationality
Source: Eur Respir J 2006; 28: Suppl. 50, 236s
Year: 2006

How many young adults are at risk of COPD?
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002

Characterization of asthma exacerbations by Arg16Gly genotype in subjects with asthma receiving salmeterol alone or with fluticasone propionate
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study
Source: International Congress 2019 – Genes and environment
Year: 2019

Is asthma different in asthmatic siblings compared to asthmatics in general population?
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD
Source: Eur Respir J 2010; 36: 494-502
Year: 2010